A ‘Smart Pill’ To Help Patients Remember To Take Meds Was Touted As New Era In Care. Now Researchers Are Pushing Back.

The researchers argue that the evidence used to approve the product — called Abilify MyCite — was not only weak, but failed to demonstrate the technology improves adherence, a key point if the goal is to improve health outcomes. In other public health news: neuron research, seasickness, surgery, scooter safety, … Read entire story.

Source: Kaiser Health News